Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HSBC Jintrust Fund Management is a China-based joint-venture asset management company focused on mutual fund management, fund sales, and related asset management services. The firm operates under the HSBC Jintrust brand and offers a broad lineup of equity, bond, money market, index, and fund-of-funds products to investors in mainland China. It is part of the broader HSBC asset management ecosystem rather than a life sciences, biotech, pharma, or healthcare operating company. Based on available public information, it remains active and is headquartered in Shanghai.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HSBC Jinxin Trust.